大鼠骨髓间充质干细胞分离与培养条件的优化研究

目的:建立和优化大鼠骨髓间充质干细胞(mesenchymal stem cells,MSCs)的分离培养条件,以获得群体均一、未分化状态保持良好的MSCs.方法:收集不同周龄大鼠骨髓细胞;以不同浓度Percoll密度梯度离心分离骨髓单个核细胞;以60%低糖DMEM40%MCDB201为基础培养基,培养24h去悬浮细胞;以不同接种密度传代培养;碱性磷酸酶染色和油红O染色考察MSCs向骨和脂肪组织分化的潜能.结果:采用57%Percoll液的分离效果优于70%Percoll液.6周龄(体重约180g)大鼠能在细胞分离的质和量上达到最佳效果.24h进行悬浮细胞去除、5×103/cm2接种密度传代培养,光镜和电镜显示MSCs增殖能力强,功能状态活跃,成脂成骨实验显示多向分化潜能保持良好.结论:优化大鼠周龄、分离液的密度、细胞培养条件及改进培养方法有助于获得多向分化潜能保持良好的均一的MSCs.     

氨基修饰的纳米纤维对人和大鼠 MSCs增殖分化的影响

目的:探讨氨基修饰后的静电纺丝纳米纤维对大鼠和人骨髓来源的间充质干细胞(Rat and human bone marrow mesenchymal stem cells, r MSCs and hMSCs)增殖及成骨分化的影响。方法:采用静电纺丝法制备聚乳酸-羟基乙酸共聚物(poly(lactic-co-glycolic acid),PLGA)纳米纤维,用氨气等离子体处理其表面来接枝氨基;通过测量PLGA纳米纤维(NF)及氨基修饰后的纳米纤维(NF-NH_2)接触角来证明修饰效果;将r MSCs和hMSCs分别接种于NF和NF-NH_2,用CCK-8试剂盒检测接种后1, 3 (4), 7天的细胞增殖;接种后的21天,用茜素红S染色(ARS)法检测细胞成骨分化情况。结果:氨气等离子体处理后纳米纤维接触角从81.28±0.33降低至53.99±0.79,说明氨基修饰后的PLGA NF亲水性增加;CCK-8结果显示氨基修饰增加了r MSCs的黏附,接种24 h后r MSCs在NF和NF-NH_2上的检测吸光值分别为0.096±0.011和0.175±0.014(P0.001),而对hMSCs黏附和增殖没有影响,接种24 h后hMSCs在NF和NF-NH_2上的检测吸光值分别为0.237±0.004和0.238±0.006(P0.05);ARS染色结果显示氨基修饰后r MSCs成骨分化增多(在NF和NF-NH_2表面ARS染色区域比例分别13.147±3.223%和36.677±5.230%),而hMSCs在修饰前后的纳米纤维上均有表达(修饰前后ARS染色比例分别为50.283±2.942%和38.254±3.272%)。结论:氨基修饰的NF可以促进大鼠来源的MSCs黏附增殖以及成骨分化,而对人骨髓来源的MSCs没有显著影响,这提示我们MSCs的增殖分化行为可能具有种属依赖性。     

脂肪干细胞的诱导分化及其来源的研究

目的:通过组织块培养法得到脂肪干细胞(adipose-derived stem cells,ADSCs),探讨其诱导分化潜能,并初步研究ADSCs的来源。方法:用脂肪组织块培养法培养原代人ADSCs。第三代ADSCs进行成脂和成骨诱导分化,分别用油红O和茜素红S染色进行鉴定。脂肪组织块培养七天后取脂肪组织进行Hematoxylin-eosin Staining(HE)染色观察ADSCs组织分布。结果:用脂肪组织块培养法成功培养出原代人ADSCs。ADSCs传代到第8代,依然保持着良好的增殖能力和细胞形态。ADSCs能成功诱导成脂肪细胞和骨细胞。通过对培养七天后的脂肪组织块进行HE染色,发现ADSCs主要分布在脂肪组织的间质血管和结缔组织周围。结论:用脂肪组织块培养出来的ADSCs具有成脂和成骨分化的潜能。ADSCs主要定位于间质血管和结缔组织周围。     

小鼠间充质干细胞诱导分化成脂肪细胞miRNA表达的变化

目的：探讨小鼠间充质干细胞（MSCs）定向诱导分化成脂肪细胞微小RNA（miRNA）表达的变化,为进一步研究miRNA调控MSCs向脂肪细胞分化的分子机制奠定基础。方法：采用全骨髓体外分离结合差速贴壁法纯化扩增C57BL／6小鼠MSCs,形态学观察细胞生长情况,并用免疫组化方法鉴定细胞表面抗原CD29、CIM4和CD34的表达。脂肪细胞分化诱导剂诱导MSCs分化为脂肪细胞,利用油红O染色,判断MSCs成脂分化情况。运用rrfiRNA芯片技术检测MSC8和脂肪细胞中差异表达的miRNA。结果：①倒置显微镜下观察,传5代后可获得均一性较高的MSCs;免疫组化显示90％以上的骨髓间质干细胞CD29、CD44阳性,CD34阴性。MSCs经脂肪诱导剂诱导后,胞内大量脂滴形成,油红O染色阳性;②基因微阵列分析表明,小鼠MSCs分化成脂肪细胞差异表达的miRNA共75个,其中20个表达上调、55个表达下调。结论：MSCs分化成脂肪细胞存在miRNA表达的变化,某些miRNA很可能具有重要的调控MSCs成脂分化的作用。     

去卵巢骨质疏松山羊骨髓基质细胞成骨分化能力的研究

目的：研究在构建的去卵巢骨质疏松山羊动物模型中,骨髓基质细胞（MSCs）的生物学特性以及其成骨能力。方法：建立去卵巢骨质疏松山羊动物模型,使用全骨髓法获取去卵巢骨质疏松山羊（实验组）和正常山羊（对照组）MSCs,流式细胞仪检测实验组和对照组细胞周期及增殖指数（PI）;地塞米松诱导21d时油红O染色,观察成脂分化比例;成骨诱导液诱导14d,碱性磷酸酶（ALP）染色、检测ALP表达量。结果：对照组PI高于实验组;地塞米松诱导后实验组脂肪细胞比例明显高于对照组;成骨诱导第7d,对照组ALP的表达量明显高于实验组。结论：去卵巢骨质疏松山羊的MSCs增殖和成骨分化能力都降低,可能与骨质疏松症的发病机理有关。     

去卵巢对SD大鼠MSCs多向分化能力的影响

通过比较有、无诱导条件下正常与骨质疏松症（OP）大鼠骨髓间充质干细胞（MSCs）骨向、脂向及软骨向的分化情况,观察去卵巢对SD大鼠MSCs多向分化能力的影响。实验分为四组：正常组、正常诱导组、OP组、OP诱导组;分别在有或无成骨、成脂、成软骨诱导条件下,评价各组的分化情况。检测发现,无诱导条件下,正常大鼠MSCs骨向及软骨向分化的能力强于OP大鼠,而OP大鼠MSCs的脂向分化能力强于正常大鼠;诱导条件下,正常大鼠MSCs对骨向及软骨向诱导剂的反应能力强于OP大鼠,而OP大鼠MSCs对成脂诱导剂的反应能力强于正常大鼠。这些结果表明,去卵巢后大鼠MSCs骨向分化能力及对成骨诱导剂的反应力下降,脂向分化能力及对成脂诱导剂的反应力增强,对软骨诱导剂的反应力下降。     

Notch信号参与BMP4诱导的间充质干细胞成骨分化及其机制的初步探讨

目的:探讨Notch信号对骨形态发生蛋白4(bone morphogenetic protein 4,BMP4)诱导间充质干细胞成骨分化的影响以及作用机制。方法:(1)DAPT或Ad-dominant-negative mutants of Notch1(Addn Notch1)和BMP4-CM处理小鼠胚胎成纤维细胞,检测早期成骨指标碱性磷酸酶(alkaline phosphatase,ALP);(2)茜素红S染色实验检测晚期成骨钙盐沉积情况;(3)半定量反转录聚合酶链反应(RT-PCR)检测成骨分化相关基因ALP,Runx2,Col1a1的表达;(4)免疫细胞化学检测p-Smad1/5/8的表达;(5)结晶紫染色和流式细胞术检测细胞的增殖及周期改变。结果:(1)DAPT抑制BMP4诱导的早期成骨分化,且呈浓度依赖性;(2)Delta-like 1(DLL1)促进BMP4诱导的成骨分化,DAPT和dn Notch1抑制BMP4诱导的成骨分化;(3)DLL1促进BMP4诱导的成骨相关基因ALP,Runx2,Col1a1的表达,DAPT抑制这些基因的表达;(4)DLL1促进BMP4诱导的细胞核内p-Smad1/5/8的表达,而DAPT抑制其表达;(5)DLL1促进BMP4诱导的细胞增殖,而DAPT抑制BMP4诱导的细胞增殖。结论:Notch信号通过BMP/Smads信号通路促进BMP4诱导的MSCs成骨分化,在此过程中也有促细胞增殖的作用。     

人体皮肤成纤维细胞的快速分离及多向分化能力鉴定

目的建立快速分离人皮肤成纤维细胞的方法,并探讨成纤维细胞在成脂、成骨、成软骨和成神经的多向分化潜能。 方法利用组织块培养法分离人体皮肤成纤维细胞,通过形态学观察、流式分析、Vimentin蛋白染色鉴定成纤维细胞;再利用生长曲线、核型分析、线粒体染色分析不同传代细胞的增殖速度,线粒体及染色体形态的改变;最后进行成纤维细胞成脂、成骨、成软骨和成神经的诱导分化实验,鉴定其多向分化潜能。两代细胞增殖速度及线料体相对量的比较采用t检验统计分析。 结果分离的皮肤成纤维细胞呈典型梭状及多角形;高表达细胞表面标记物CD90 （NCF1,NCF2占比分别为99.9%,98.7%）和CD73 （NCF1,NCF2占比分别为98.2%,85.6%）,但极少表达造血干细胞标记物CD34 （NCF1,NCF2占比分别为1.8%,2.6%）;细胞Vimentin蛋白表达呈阳性,阳性率为100%;对细胞生长曲线进行分析,表明分离后不同代次细胞增殖差异无统计学意义（t?= 1.586,P?= 0.1567）;线粒体相对含量统计分析,同一株细胞系第5代（相对荧光强度值：6876±577.8）与第10代（相对荧光强度值：7371±471.9）之间的差异无统计学意义（t?= 0.664,P?= 0.543）;核型分析分别显示传代后保持染色体数目为正常46条且形态无明显异常;经诱导后成纤维细胞可向成脂、成骨、成软骨和类神经分化。 结论利用组织块培养法分离出的人体皮肤成纤维细胞状态稳定,增殖能力强,具有成脂、成骨、成软骨和成神经多向分化诱导潜能,为细胞移植修复骨损伤、软骨损伤和神经损伤性疾病的临床研究提供细胞来源及实验依据。     

补骨脂素对大鼠骨髓间充质干细胞成骨及成脂分化的影响

目的:探讨补骨脂素对大鼠骨髓间充质干细胞成骨及成脂分化的影响及其可能机制。方法:选取3月龄无特定病原体级健康雌性SD大鼠25只,通过切除卵巢建立绝经大鼠模型。6周后,通过全骨髓贴壁法分离BMSCs并进行原代和传代培养,传至3代后进行成骨和成脂诱导,并按补骨脂素浓度梯度0、5、10、15、20μmol/L进行处理。细胞增殖2周后,通过碱性磷酸酶(ALP)染色实验和油红O染色观察BMSCs成骨和成脂的分化,应用蛋白免疫印迹法测定核心结合蛋白因子RUNX2、骨钙素(OCN)、增强子结合蛋白β(C/EBP-β)、过氧化物酶体增殖物激活受体γ(PPAR-γ)的表达。结果:成骨诱导BMSCs在补骨脂素的作用下ALP染色呈阳性反应,且补骨脂素的浓度为15μmol/L时阳性反应最强。RUNX2、OCN蛋白的表达随着补骨脂素浓度的升高而升高,差异具有统计学意义(P0.05)。与空白组比较,成脂诱导BMSCs在补骨脂素的作用下油红O染色阳性反应程度出现下降,补骨脂素浓度为20μmol/L时,油红O染色阳性率最低。C/EBP-β、PPAR-γ蛋白的表达均随着补骨脂素浓度的升高而降低,差异具有统计学意义(P0.05)。结论:补骨脂素体外可增强BMSCs成骨分化作及抑制BMSCs成脂分化,可能与其调节RUNX2、OCN、C/EBP-β和PPAR-γ蛋白的表达有关。     

人骨髓间充质干细胞在成年大鼠脑内的迁移及分化

骨髓间充质干细胞 (mesenchymalstemcells,MSCs)是目前备受关注的一类具有多向分化潜能的组织干细胞 ,体外可以分化为骨、软骨、脂肪等多种细胞。因此 ,MSCs是细胞治疗和基因治疗的种子细胞之一。为了探索MSCs的迁移和分化趋势 ,为帕金森病 (Parkinsondisease,PD)的干细胞治疗提供理论和实验依据 ,本实验将体外扩增并转染增强型绿色荧光蛋白 (enhancedgreenfluorescentprotein ,EGFP)的人骨髓MSCs注入PD大鼠脑内纹状体 ,观察了人骨髓MSCs在大鼠脑内的存活、迁移、分化以及注射MSCs前后大鼠的行为变化。结果表明 ,人骨髓MSCs在大鼠脑内可存活较长时间 ( 10周以上 ) ;随着时间的延长 ,MSCs迁移范围扩大 ,分布于纹状体、胼胝体、皮质以及脑内血管壁 ;免疫组化法检测证实MSCs在大鼠脑内表达人神经丝蛋白 (neurofilament,NF)、神经元特异性烯醇化酶 (neuron specificeno lase,NSE)以及胶质原纤维酸性蛋白 ( glialfibrillaryacidprotein ,GFAP) ;PD大鼠的异常行为有所缓解 ,转圈数由 8 86±2 0 9r/min下降到 4 87± 2 0 6r/min ,统计学分析P <0 0 5为差异显著。以上观察结果表明 ,骨髓MSCs有望成为治疗PD的种子细胞     

Differential effect of ionizing radiation exposure on multipotent and differentiation‐restricted bone marrow mesenchymal stem cells

Debilitating effects of bone marrow from ionizing radiation exposure has been well established for hematopoietic stem cells; however, radiation toxicity of mesenchymal stem cells (MSCs) has been controversial. The present study addressed if ionizing radiation exposure differently affected bone marrow MSCs with various differentiation commitments. Mouse bone‐marrow‐derived MSCs, D1 cells of early passages (≤5 passages; p5) maintained the complete characteristics of multipotent MSCs, whereas, after ≥45 passages (p45) the differentiation capability of D1 cells became partially restricted. Both p5 and p45 D1 cells were subjected to single dose irradiation by radioactive isotope ¹³⁷Cs. Radiation treatment impaired cell renewal and differentiation activities of p5 D1 cells; however, p45 D1 cells were less affected. Radiation treatment upregulated both pro‐ and anti‐apoptotic genes of p5 D1 cells in a dose‐dependent manner, potentially resulting in the various apoptosis thresholds. It was found that constitutive as well as radiation‐induced phosphorylation levels of histone H2AX was significantly higher in p45 D1 cells than in p5 D1 cells. The increased repair activity of DNA double‐strand breakage may play a role for p45 D1 cells to exhibit the relative radioresistance. In conclusion, the radiation toxicity predominantly affecting multipotent MSCs may occur at unexpectedly low doses, which may, in part, contribute to the catabolic pathology of bone tissue. J. Cell. Biochem. 111: 322–332, 2010. © 2010 Wiley‐Liss, Inc.     

Differentiation potential of bone marrow mesenchymal stem cells in duck

The bone marrow mesenchymal stem cells （MSCs） are multipotent stem cells which can differentiate into mesenchymal cells in vitro. In this study, MSCs in duck were isolated from bone marrow by density gradient centrifuge separation, purified and expanded in the me- dium. The primary MSCs were expanded for 11 passages. The different-passage MSCs were induced to differentiate into osteoblasts and neuron-like cells. Karyotype analysis indicated that MSCs kept diploid condition and the hereditary feature was stable. The different- passage MSCs expressed CD44, ICAM-1 and SSEA-4, but not CD34, CD45 and SSEA-1 when detected by immunofluorescence staining There was no significant difference among the positive rates of passages 2, 6 and 8 （P 〉 0.05）, but a significant difference existed among those of passages 2, 6, 8 and 11 （P 〈 0.05）. After the osteogenic inducement was added, the induced different-passage MSCs expressed high-level alkaline phosphatase （ALP）, and are positive for tetracycline staining, Alizarin Red staining and Von Kossa staining. After the neural inducement was added, about 70% cells exhibited typical neuron-like phenotype, the induced different-passage MSCs expressed Nestin, neuron-specific enolase （NSE） and glial fibrillary acidic protein （GFAP） when detected by immunofluorescence staining. There was no significant difference among the positive rates of passages 3, 4 and 6 （P〉0.05）, but a significant difference existed among those of passages 3, 4, 6 and 8 （P〈0.05）. These results suggest that MSCs in duck were capable of differentiating into osteoblasts and neuron-like cells in vitro.     

Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells

In recent years, a large number of studies have contributed to our understanding of the immunomodulatory mechanisms used by multipotent mesenchymal stem cells (MSCs). Initially isolated from the bone marrow (BM), MSCs have been found in many tissues but the strong immunomodulatory properties are best studied in BM MSCs. The immunomodulatory effects of BM MSCs are wide, extending to T lymphocytes and dendritic cells, and are therapeutically useful for treatment of immune-related diseases including graft-versus-host disease as well as possibly autoimmune diseases. However, BM MSCs are very rare cells and require an invasive procedure for procurement. Recently, MSCs have also been found in fetal-stage embryo-proper and extra-embryonic tissues, and these human fetal MSCs (F-MSCs) have a higher proliferative profile, and are capable of multilineage differentiation as well as exert strong immunomodulatory effects. As such, these F-MSCs can be viewed as alternative sources of MSCs. We review here the current understanding of the mechanisms behind the immunomodulatory properties of BM MSCs and F-MSCs. An increase in our understanding of MSC suppressor mechanisms will offer insights for prevalent clinical use of these versatile adult stem cells in the near future.     

间充质干细胞分化为内皮细胞的意义和细胞学基础

间充质干细胞(mesenchymalstemcells,MSCs)主要存在于骨髓中,是多潜能干细胞,在脐血、外周血、脂肪、皮肤等多种组织中也相继分离出MSCs。MSCs具有独特的免疫特性,在异种异体环境内长期存在,使其临床应用前景更为广泛。目前,MSCs的分离培养、诱导分化及鉴定体系已趋成熟,理论上可分化为所有中胚层来源的细胞,内皮细胞来源于中胚层,因此MSCs具有分化为内皮细胞的可能性。本文对MSCs内皮分化意义和细胞学基础及其新近的研究进展作一综述。     

The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105).

Mesenchymal stem cells are multipotent cells resident in the bone marrow throughout adulthood which have the capacity to differentiate into cartilage, bone, fat, muscle, and tendon. A number of monoclonal antibodies raised against human MSCs have been shown to react with surface antigens on these cells in vitro. A protein of molecular mass 92 kDa was immunoprecipitated using the SH-2 monoclonal antibody. This was purified and identified by peptide sequencing analysis and mass spectrometry as endoglin (CD105), the TGF-beta receptor III present on endothelial cells, syncytiotrophoblasts, macrophages, and connective tissue stromal cells. Endoglin on MSCs potentially plays a role in TGF-beta signalling in the control of chondrogenic differentiation of MSCs and also in mediating interactions between MSCs and haematopoietic cells in the bone marrow microenvironment.     

BMP-13 Emerges as a Potential Inhibitor of Bone Formation

Bone morphogenetic protein-13 (BMP-13) plays an important role in skeletal development. In the light of a recent report that mutations in the BMP-13 gene are associated with spine vertebral fusion in Klippel-Feil syndrome, we hypothesized that BMP-13 signaling is crucial for regulating embryonic endochondral ossification. In this study, we found that BMP-13 inhibited the osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells (BM MSCs) in vitro. The endogenous BMP-13 gene expression in MSCs was examined under expansion conditions. The MSCs were then induced to differentiate into osteoblasts in osteo-inductive medium containing exogenous BMP-13. Gene expression was analysed by real-time PCR. Alkaline phosphatase (ALP) expression and activity, proteoglycan (PG) synthesis and matrix mineralization were assessed by cytological staining or ALP assay. Results showed that endogenous BMP-13 mRNA expression was higher than BMP-2 or -7 during MSC growth. BMP-13 supplementation strongly inhibited matrix mineralization and ALP activity of osteogenic differentiated MSCs, yet increased PG synthesis under the same conditions. In conclusion, BMP-13 inhibited osteogenic differentiation of MSCs, implying that functional mutations or deficiency of BMP-13 may allow excess bone formation. Our finding provides an insight into the molecular mechanisms and the therapeutic potential of BMP-13 in restricting pathological bone formation.